THE maintenance of protein metabolism is of fundamental importance in cellular viability. Proteins in the heart include those with structural, nuclear, and enzymatic function, as well as the diverse group of contractile proteins which are responsible for the main function of the heart, i.e., that of fluid ejection. Alterations in contractile function are known to occur after prolonged exposure to various stresses, and the present review investigates the thesis that these may be related ultimately to changes in cardiac protein metabolism.
Protein metabolism has been measured by assay of synthesis and degradation. Synthesis has been estimated mainly from the incorporation of radioactively labeled amino acids into proteins both in vivo and in vitro. Degradation of protein has been measured from the loss of labeled or unlabeled amino acids from the heart in vitro. In vivo, several methods have been used: first, the rate of decline of radioactivity in the protein; second, the difference in the rate of synthesis and growth; and third, the "turnover" of labeled amino acids. A variety of problems are associated with measurements of both synthesis and degradation of proteins which should be considered before discussing the effects of stress.
Cardiac Protein Synthesis and Labeled Amino Acid Precursors
Protein synthesis may be estimated from the incorporation of radioactively labeled amino acids into protein following their administration both in vivo or in vitro, and is based on a precursor-product relationship: mol amino acid incorporated dpm incorporated into protein (dpm/mol amino acid) precursor
Although the principle seems simple, the application has been difficult, mainly due to the major problem of determining the specific activity of the labeled amino acid in the precursor pool for protein synthesis. The latter may not be accomplished easily, since often it is not possible to assay identical experimental samples of tissue because of the different procedures used for the isolation of proteins and the tRNA amino acyl pool. Therefore calculations of protein synthesis have long been made, using the specific activity of the amino acid in the extracellular or intracellular spaces. However, these estimations may be only approximations because of possible differences in the specific activities of the amino acids in these spaces and the relationship of these spaces to the precursor pool. For example, intracellular phenylalanine specific activity equals that in the extracellular space at certain concentrations Schreiber et al., 1973; McKee et al., 1978) whereas lysine specific activity reaches approximately 70% of that in the extracellular space even after several hours of constant infusion (Schreiber et al., 1966 (Schreiber et al., , 1973 Waterlow et al., 1967) . The latter has been ascribed to dilution of radioactivity by unlabeled amino acid of the same species released by intracellular protein degradation (Gan and Jeffay, 1967) . The specific activity of the amino acids in the precursor tRNA pool itself is in close equilibrium with that in the extracellular (Hider et al., 1971) or in the intracellular space (Mowbray et al., 1974) . More recent data suggest that, for most amino acids, the precursor pool specific activity lies somewhere between the intra-and extracellular pool specific activities (Vidrich et al., 1977; Robertson and Wheatley, 1979) , and since both values are usually obtainable, approximations of synthesis may be made.
The major methods of administration of radioactive amino acids for the measurements of protein synthesis have been pulse labeling or continuous 602 CIRCULATION RESEARCH VOL. 48, No. 5, MAY 1981 perfusion. Pulse labeling, usually used in vivo, results in specific activities in the extracellular, intracellular, and tRNA pools which are continually changing at different rates. Protein synthesis may be estimated if the specific activity of the label in the precursor pool is measured simultaneously with the incorporation of the label into the protein and is more valid if determinations are made at more than one time following administration of the label. It now is generally accepted that more accurate assay of synthesis may be obtained with the constant perfusion method (Schreiber et al., 1966; Waterlow et al., 1967; Garlick, 1978) with constant specific activity of the labeled amino acid, since this permits the specific activity of the amino acid in the precursor pool to reach some semblance of stability. Under these circumstances, protein synthesis measured at hourly intervals in vitro has been found to be linear (Schreiber et al., 1966) . Measurement of relative synthesis of different cardiac proteins obviates the necessity of determining the specific activity of the precursor pool, provided that the same precursor pool is used for their synthesis. It has been reported (Fern and Garlick, 1976) that, in some non-cardiac tissues, the precursor pool specific activity for the same amino acid may be different for the synthesis of various proteins. However, identical values of relative synthesis of cardiac contractile proteins have been obtained with phenylalanine and lysine used simultaneously (Evans et al., 1978 (Evans et al., , 1981 despite the widely different patterns of equilibration of the two amino acids Schreiber et al., 1973) suggesting that the same precursor pool is used for the synthesis of the proteins studied.
It is evident that any assay of protein synthesis in stress states can only be interpretated with consideration of the problems mentioned above.
Cardiac Protein Degradation
Protein degradation has been measured mainly from the loss of radioactivity from proteins previously labeled with 14 C or 3 H amino acids, but reutilization of intracellular amino acids has been a major pitfall in such estimations. The degree of reutilization varies with the amino acid used; e.g., the degradative half life of skeletal muscle protein in vivo was slowest with [
14 C]selenomethionine and most rapid with aspartate and glutamate prelabeled with [ U C]CO 3~2 (Millward, 1979) . The latter amino acids are metabolized rapidly and are less available for reutilization. Similarly, in the perfused heart, the degradative rate measured with [ (Schreiber et al., 1973) . The degree of reutilization depends not only on the amino acid used but on its extracellular concentration. For example, with phenylalanine, for which the intracellular pool is small, as the external concentration is increased, reutilization is minimized (Schreiber et al., 1973; Rannels et al., 1975) . Thus, accurate assays of protein degradation using decline of protein specific activity or release of labeled or unlabeled amino acids may be impossible unless reutilization is prevented by inhibitors of protein synthesis (Schreiber et al., 1972a (Schreiber et al., , 1973 or use of nonreutilizable labels. Although the former may be used when measuring protein degradation, the inhibitors of synthesis themselves may slow protein degradation or may not completely block new protein synthesis (Rannels et al., 1975; . The use of synthetic inhibitors in vivo is not feasible, and estimates of protein degradation have been suggested with the use of nonreutilizable amino acids or other substrates which label proteins or prosthetic groups. Methylhistidine, a component of muscle protein, is not reutilized (Morgan and Wildenthal, 1980) ; however, its content in cardiac muscle is so low that its use may not be feasible. 5-Aminolevulinic acid (used as a label of heme) has been used as an index of cytochrome c degradation and is discussed below.
The assay of "turnover" has been useful in studies in vivo. Turnover is the replacement of any protein, and the term reflects both synthesis and degradation (see Schimke, 1976) . In the steady state where synthesis equals degradation, turnover may be equated with the fractional rate of degradation. Confusion arises with the word "turnover" when it is equated with the fractional rate of degradation in the non-steady state, in which synthesis may not equal degradation.
Still another approach to studying cardiac protein degradation has been that involved with cardiac proteinase activity (Morgan and Wildenthal, 1980) . There has been some correlation between the lysosome system and the rate of proteolysis in the perfused organ; e.g., some inhibitors of lysosome proteinase activity such as chloroquine also decrease degradation in the perfused organ (Wildenthal and Crie, 1980) , and some proteases found in cardiac homogenates degrade proteins in these homogenates at rates similar to those derived from release of phenylalanine in the perfused heart (Clark et al., 1980) . However, lysosome activity does not always correlate with radioactive measurements of protein degradation; for example, dissociation is seen following starvation or recovery from thyrotoxicosis (Wildenthal and Crie, 1980) . There have been some attempts to assign specific enzymes to degradation of muscle cell proteins and to separate them from non-myocyte enzymes. Thus, Ca 2+ -activated proteases have been found to degrade myofibrillar proteins (Reddy et al., 1975) . However, the basic problem still remains unsolved as to the source of the enzymes, myocyte or non-myocyte, and what controls the process in the intact organ. The mechanism in the intact cell is still unknown, but it has been suggested that myofibrillar degradation may be a two-step process with the initial degradation yielding peptides which are then trans- Schreiber et al. 603 ferred to the lysosomes for further breakdown to amino acids (Gerard and Schneider, 1979) .
At this time, the assays of cardiac total protein degradation, at best, are indices of breakdown of proteins from a mixed population of cells, and to assign this process to a physiological mechanism resulting in ultimate alteration of contractile function in stress may not be warranted.
Cardiac Protein Synthesis in Hemodynamic Overload
The hypertrophy of the heart in response to increased work load is well known, but the evaluation of protein synthesis in the two types of hemodynamic overload, i.e., afterload (increased outflow resistance) and preload (volume loading or valvular insufficiency) is of major interest since the hypertrophy and response to therapy in the two types of stress are not the same (Hurst, 1974) . The protein synthetic response in vivo has been studied mainly in experimental aortic stenosis, and the results have not been entirely consistent. Increased ventricular protein or myosin synthesis has followed production of experimental aortic stenosis (Gudbjarnason et al., 1966; Morkin et al., 1972) ; decreased synthesis in the first day after operation (Zimmer et al., 1972) and increased synthesis even in sham-operated animals (Moroz, 1967) have been reported. The variable results, especially in acute studies, point to the difficulties in estimating synthesis with pulse labeling, particularly in the face of marked endocrine and neurological homeostatic mechanisms which follow operative procedures.
The quantification of synthesis in the period immediately following onset of the stress is facilitated in models in vitro, since the hemodynamic stress is not applied until the hearts have been removed and equilibrated outside the body. There has been general agreement that protein synthesis increases rapidly with outflow resistance applied to the ventricle under study (Schreiber et al., 1966 (Schreiber et al., , 1975 Kako and Minelli, 1969; Hjalmarson and Isaaksohn, 1972) . Similar findings have been seen with the cardiac papillary muscle under increased tension (Peterson and Lesch, 1972) and with working loaded skeletal muscle (Laurent and Millward, 1980) .
In chronic volume loading, in vivo, Tomita (1966) described increased protein synthesis. However, this has not been seen consistently in acute volume loading (Schreiber et al., 1966 (Schreiber et al., , 1975 . In isolated guinea pig hearts with constant coronary perfusion, right ventricular protein synthesis did not increase with volume loading but did increase with augmented outflow resistance (Schreiber et al., 1975) . Furthermore, with the isolated superfused papillary muscle, Peterson and Lesch (1972) showed greater incorporation of phenylalanine into protein with electrically stimulated development of isometric tension than with passive stretch. The augmented protein synthesis in afterload stress appears to be related to the increased pressure rather than to indices of contraction such as the degree of ventricular wall motion ("amplitude") or dP/dt max . For example, elevated Ca 2+ levels of 4.8 mM with normal outflow resistance increase dP/dt ma x and "amplitude" to the same degree as seen with afterload, but protein synthesis is not increased above control levels (Schreiber et al., 1977b) .
The data at present indicate that, although hypertrophy follows experimental preload and afterload stresses, early augmented protein synthesis is seen mainly with afterload and apparently is due to the increased pressure per se. The lack of initial response to volume loading does not preclude later changes in synthesis but does suggest that one of the major differences in developing hypertrophy between the two stresses may be temporal and quantitative. Whether there are qualitative alterations in total or specific proteins remains to be clarified.
Protein Degradation in Hemodynamic Overload
Although it now has been accepted that hypertrophy following increased afterload is due mainly to increased protein synthesis, the status of protein degradation in this stress has not always been clear. There are two problems to be considered: first, what is the status of degradation during the stage of tissue growth or increasing mass? Second, what happens to protein degradation in the period immediately following the onset of the stress; i.e., does an increase in degradation occur and is this the trigger initiating augmented protein synthesis?
Early data obtained from the decline of radioactive amino acids in the tissues raised the possibility that increased growth of loaded skeletal or cardiac muscle was due to decreased protein degradation (Goldberg, 1969; Rabinowitz and Zak, 1972) . However, as mentioned above, the decrease may have been due to reutilization of the particular amino acids used in the studies. In the perfused heart, when protein synthesis and reutilization of amino acids was inhibited, the release of labeled lysine and phenylalanine in pressure stress was not slowed (Schreiber et al., 1972a (Schreiber et al., , 1973 . In studies in vivo, if one assayed myosin degradation from the rate of loss of radioactivity from pre-labeled cardiac myosin following aortic coarctation, the decrease in specific radioactivity of the myosin was slower than that in sham-operated animals. However, if myosin content also was taken into consideration, then degradation of myosin was increased along with increased synthesis (Morkin et al., 1972) . Similar findings were reported recently in hypertrophying skeletal muscle in which estimates of total protein degradation were obtained from the fractional rate of synthesis measured with radioactive amino acids and the growth and protein content of the hypertrophying muscle. At no time during the study was there any evidence that protein degradation had 604 CIRCULATION RESEARCH VOL. 48, No. 5, MAY 1981 slowed and, indeed, after 4 days degradation was increased as mass increased (Laurent and Millward, 1980) . Although degradation of total protein and myosin is not slowed in developing hypertrophy, evidence has been presented that left ventricular degradation of cytochrome c could be turned off in response to aortic banding . This was inferred from the slowing of the rate of decline of 3 H-labeled-5-aminolevulinic acid (used as a heme label) in the cytochrome. 5-Aminolevulinic acid is cleared rapidly and thus not reutilized, but evidence has been reported that the heme molecule itself is reused both in skeletal (Booth et al., 1977) and cardiac muscle (Ord and Wildenthal, 1980) . This would suggest that the apparent slowing of degradation of cytochrome c might be due to reutilization of the heme.
In discussing the degradation of protein in the period immediately following stress, one is tempted to consider the heart as a mechanical device or pump working against a stress as afterload, with the expectation that increased wear and tear would cause increased degradation which in itself could act as the trigger initiating protein synthesis. Evidence against this has been seen both in vitro and in vivo. In acute pressure stress in vitro, the release of amino acids was not increased in afterload even when reutilization was minimized (Schreiber et al., 1973) . Similarly, in recent studies of the perfused rat heart, it was shown that, although inhibition of degradation may be substrate related, increased work load did not increase protein degradation . Recently simultaneous assay of protein synthesis (measured by constant infusion of [ 14 C]proline) and protein degradation (from the rates of synthesis and growth of protein mass) in skeletal muscle suggested that, although protein degradation was increased later in response to hypertrophy (after 4 days), there was no increase in degradation during the first 2 days even though protein synthesis was augmented (Laurent and Millward, 1980) . It would appear therefore that the hypertrophic response to afterload in the heart or increased workload in skeletal muscle is one of augmented protein synthesis and not decreased degradation. As the stress continues, degradation increases to parallel the increased synthesis. It would appear also that the initial response to pressure is not a sudden increase in protein degradation, and the latter does not appear to be the trigger that initiates the sequence leading to the augmented synthesis in hypertrophy.
The Trigger Mechanism Leading to Augmented Synthesis in Hemodynamic Overload
The sequence of events leading from the onset of overload to augmented protein synthesis has been studied mainly for afterload. Early studies with microsomes and polysomes isolated from perfused afterloaded hearts showed that there was increased protein synthesis (peptide elongation) in subcellular systems (Schreiber et al., 1967) and this was seen also in other models (Moroz, 1967; Kolbel et al., 1968) . This augmented synthesis was prevented by perfusion with actinomycin during application of afterload (Schreiber et al., 1968) . Since actinomycin was known to be an inhibitor of RNA synthesis, this suggested that an early response to afterload was increased synthesis of RNA. There has been general agreement that RNA increases after onset of afterload (Nair et al., 1968; Morkin, 1971) , but the type of RNA involved in the initial response was not clear from the earlier data. After aortic banding in vivo, Nair et al. (1968) found that polymerase I activity (rRNA synthesis) was increased after 1 day. However, with in vitro perfusion, isolated nuclei taken from afterloaded ventricles demonstrated increased polymerase II (mRNA synthesis) activity by 20 minutes and then increased rRNA synthesis thereafter (Schreiber et al., 1969) . Similar data have been reported for other models (Kako et al., 1972; Cutiletta et al., 1978) . Recent studies with nuclei obtained from normal hearts and subjected to hydrostatic pressure showed increased polymerase II activity which was inhibited if nuclei were suspended in a-amanitin [a specific inhibitor of mRNA synthesis (Versteegh et al., 1975) ] . The pressure-induced polymerase II activity required cytosol . Cytosolic extracts from hypertrophied tissues also have been reported to stimulate protein synthesis by increasing the translational ability of RNA (Hammond et al., 1979) .
It is of interest to speculate that pressure itself stimulates increased mRNA synthesis, but the actual mechanism is not yet known. The increased mRNA synthesis is followed shortly by increases in rRNA, and both lead to increased protein synthesis which is the response to afterload. However, it should be emphasized that most of the studies cited above have dealt with assays of mixed populations of cells or subcellular organelles, and even differential centrifugation may not exclude mixing. The recent use of myocytes isolated from the heart may permit study of myocyte nuclei and their subcellular systems, but at this time there is a question as to the percentage of viable cells so isolated, and the decreased viability would raise questions concerning interpretation of data from such cells. It has been known that incorporation of [
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RNA synthesis. It may be suggested that either new sites are made available by derepression or the rate of synthesis is increased at existing sites. These problems must be addressed before the trigger mechanism can be identified.
Synthesis of Specific Proteins in Hemodynamic Overload
Connective Tissues
It appears self evident that, as the heart increases in size and mass, the connective tissues should increase proportionately to maintain internal structural integrity, but there appears to be a disproportionate change in the connective tissues with different stresses. Early studies with hemodynamic overload in vivo demonstrated increases in [ 3 H]thymidine incorporation into nuclei of non-myocyte cells (Meerson et al., 1964; Morkin, 1971 ) suggesting proliferation of these cells, and indeed increased collagen synthesis measured by hydroxyproline content (Buccino et al., 1969) and cardiac protocollagen proline hydroxylase activity (Lindy, 1972) was seen after experimental aortic stenosis. However, early preferential synthesis of cardiac collagen was not seen with in vitro pressure stress when conversion of [
C]proline to [
I4 C]hydroxyproline was measured (Schreiber et al., 1970) . The difference in response may have been due to the time of study following onset of the stress, but differences in connective tissue synthetic response also have been noted with different stresses, with little increase in fibrosis in anemia (Bartsova et al., 1969) , in essential hypertension (Lund et al., 1979) , or in hypertrophy with valvular insufficiency (LeClerc et al., 1976) . On the other hand, increased fibrosis has been noted with hypoxia (Bartsova et al., 1969) , and it has been suggested that increased collagen content in pressure-stressed hearts in vivo may be due to necrosis which follows the experimental induction of the stress (Bishop and Melsen, 1976) . Thus, the data would suggest that alterations in synthesis of cardiac connective tissues vary with the model, the type and duration of the stress, as well as the possible association of cardiac anoxia and/or ischemia.
Mitochondria
The response of mitochondria to stimuli inducing hypertrophy has been reviewed by Rabinowitz and Zak (1975) and Wikman-Coffelt et al. (1979) . In pressure stress, there appears to be an early dissociation between mitochondrial and myofibrillar mass with a preferential increase in mitochondrial components due presumably to increased synthesis, decreased degradation, or both. Such preferential increases have not been seen with the acute stress model in vitro (Schreiber et al., 1971) . After 3 days of in vivo afterload, the relative volume of mitochondria falls as the myofibrillar content increases (Page et al., 1971) , and with prolonged pressure stress, there is general agreement that mitochondrial mass decreases with respect to ultimate myofibrillar mass (Anversa et al., 1971; Rabinowitz and Zak, 1975) . Recently, an increase in mitochondrial DNA has been seen early in the response to hemodynamic overload (Rajamanickam et al., 1979) , but the relationship between this increase and mitochondrial protein synthesis remains to be clarified. Although the ultimate disproportion between mitochondria and myofibrils may be related to ultimate contractile dysfunction because of deficient energy availability, the causes of the disproportion are not yet known.
Contractile Proteins
Correlated with its action as a contractile protein, myosin acts as an enzyme (myosin ATPase), and its activity apparently changes in the hypertrophied heart responding to chronic hemodynamic overload. The changes in enzymatic activity appear to be dependent on the severity and chronicity of the stress (for review see Swynghedauw et al., 1976; Wikman-Coffelt et al., 1979; Scheuer and Bahn, 1979) , and may be related to alterations in the synthesis of the molecule. Cardiac myosin consists of two heavy chains (HC) and two each of two different light chains (LCi and LC 2 ) (Weeds and Frank, 1973; Leger et al., 1975) . Ventricular myosin has been shown to exist as several isozymes in the normal and abnormal heart (Flink and Morkin, 1977; Flink et al., 1979; Hoh et al., 1979) with differences in the HC subunits. The active site of the myosin molecule has been reported to be localized in cardiac HC , but the enzymatic activity may require one of the light chains Wagner and Weeds, 1977) . Although the myosin ATPase is decreased in some stress models, no consistent alteration in LC structure, proportion, or amino acid composition has been shown (Katagori and Morkin, 1974; Shiverick et al., 1976) .
With this brief background, data concerning synthesis and degradation of myosin in overload may be more meaningful. By use of pulse labeling or constant infusion, the fractional rate of degradation of cardiac myosin in vivo has been found to have a half time of approximately 8-12 days (Kimata and Morkin, 1971; Wikman-Coffelt et al., 1973; Wyborny et al., 1978) . It generally is agreed that, with afterload, an early response to the stress is an increase in synthesis of myosin both in vitro with studies of synthesis (Schreiber et al., 1970 ) and in vivo with turnover studies (Morkin et al., 1972) . As mentioned above, with prolongation of the overload, degradation of myosin appears to be increased as well (Morkin et al., 1972) .
It is well established that the subunits HC and LCs are not synthesized at the same rates, indicating independent synthesis of these subunits. More rapid synthesis of cardiac HC than LCs has been reported both in vivo and in vitro (Wikman-Coffelt 606 CIRCULATION RESEARCH VOL. 48, No. 5, MAY 1981 LaGrange and Low, 1976; Zak et al., 1977; Evans et al., 1978) . With afterload produced in vitro, relative synthesis of right ventricular myosin HC compared to LCs incr ased after 3 hours of stress (Evans et al., 1978) . In contrast, after in vivo banding of the aorta, labeling of the light chains with radioactive ammo acids was increased relative to the HC 2-4 days after the aortic banding (Zak, 1977) . The differences may be due to the times of assay after onset of the stress or to differences in the ventricles. Similarly, the rates of synthesis of other contractile proteins in the myofibril are not the same. In normal hearts in vivo, the fractional turnover rates have been HC = actinin = tropomyosin > actin > LC, = LC 2 . Similar, but not identical, patterns of fractional rates of synthesis were found in hearts in vitro perfused with normal flow and pressure loads for 3 hours with labeled phenylalanine and lysine at constant specific activities. When the molar proportions of the contractile proteins in the cell were considered, then the relative molar synthesis was in the order of actin > HC > LC 2 > LCi > tropomyosin (Evans et al., 1981) . Thus, the pattern obtained from fractional rates of synthesis may not be the same as that obtained from quantities synthesized, and this should be considered in comparing different studies.
Specific conclusions relating alterations in contractile protein synthesis (or degradation) to changes in enzyme action or contractile function are not warranted at this time. However, the findings of alterations in myosin antigenicity with alterations in proportions of myosin isozymes (Schwartz et al., 1978; Lompre et al., 1979) suggest that with hemodynamic stress there may be induced myosin isozyme synthesis. The disproportionate increase in HC synthesis compared to that of LCs early in afterload (Evans et al., 1978) would be consistent with this suggestion. Induction of HC isozyme synthesis also has been shown with thyroxine administration (Flink and Morkin, 1977; Flink et al., 1979) . Such alterations in isozyme synthesis could lead to changes in the functional activity of the myosin.
Cardiac Arrest and Protein Metabolism
Metabolism in the arrested heart recently has been of interest because of the large increase in cardiac surgery in the last decade and the use of arrest during the procedures. Protein synthesis in the arrested viable heart may remain at normal levels for short periods (3 hours) (Schreiber et al., 1977a) . Although denervated non-contracting skeletal muscle shows decreased protein synthesis leading to atrophy (Young, 1970) , the times of study are not comparable to the acutely arrested heart. Protein synthesis is not the same in all forms of cardiac arrest. In aerobically perfused hearts arrested by high extracellular K + concentrations (16 mEq/liter), synthesis apparently is normal with normal levels of high energy phosphates and low lactate production (Schreiber et al., 1977a) . However, in cultures of chick embryo cardiac cells, incorporation of [ 14 C]lysine into myosin and actin was slower in quiescent cells than in cultured beating cells. However, the viability of the quiescent cells may have been compromised in the media used (Nihei and Steinberg, 1978) . Furthermore, in cardiac arrest with hypocalcemia (Ca 2+ = 0) or anoxia without concomitant high extracellular K + concentrations, protein synthesis is inhibited markedly (Schreiber et al., 1977a (Schreiber et al., , 1977b with sharp declines in ATP, creatine phosphate, glycogen and intracellular K + accompanied by high lactate production. The deleterious effects of arrest induced by anoxia are prevented if the introduction of anoxic perfusate is simultaneous with a high extracellular K + concentration, and protein synthesis is near normal with restoration of function with normal reperfusion (Schreiber et al., 1977a) . With hypocalcemic arrest, there is apparent cessation of degradation as well as synthesis with protein nitrogen higher than in perfused controls (Schreiber et al., 1977b) , and there is no restoration of function with reperfusion with solutions containing normal levels of calcium.
The available data indicate that protein synthesis is not inhibited in short-term cardiac arrest as induced by high extracellular K + concentration (16 mEq/liter). This is of prime importance in maintaining cardiac viability and should be considered in operative intervention which may require arrest for the procedure.
Anoxia and/or Ischemia and Cardiac Protein Synthesis
It generally is accepted that the major fraction of energy used in the heart is expended in muscle contraction against a load, and the amount of oxygen required for cellular protein synthesis is relatively small (Clifford et al., 1972; Ayuso and Parrilla, 1975) . Thus, papillary muscles superfused in vitro (37°C) did not decrease protein synthesis until O 2 levels in the bath were 10% or lower (Lesch et al., 1976) and in intact perfused hearts arrested for 3 hours with high extracellular K + concentration (16 mEq/liter), protein synthesis was decreased only minimally even in total anoxia. However, this does not imply that there is no energy requirement for protein synthesis, but there is a critical level and duration of oxygen deprivation for which inhibition may be irreversible. Thus, in intact contracting perfused hearts in vitro, anoxia leads to progressive loss of high-energy phosphates and inhibition of protein synthesis , and these become irreversible with prolonged anoxia (Schreiber et al., 1977a) .
In vivo, oxygen deprivation may be produced by anoxia or ischemia which differ mainly in terms of perfusion. By definition, in ischemia there may be CARDIAC PROTEIN METABOLISM IN STRESS/Schreiber et al. 607 an inability to remove metabolites as well as an imbalance between supply and demand of O 2 (Hearse, 1977) . In anoxia (or hypoxia) perfusion may be normal, but oxygen levels in the perfusate or plasma may be inadequate. Oxygen deprivation in both, even for short periods, results in increased protein breakdown (particularly in mitochondrial proteins) (Aschenbrenner et al., 1971) , but myofibrillar proteins are initially more resistant. With continued oxygen deprivation, myofibrillar disruption and enzyme loss also occur (Jennings et al., 1974; Hearse, 1977) . There may be repair of the ultrastructural damage if the oxygen deprivation is of brief duration (Hearse, 1977) indicating that the protein synthetic machinery is not irreversibly damaged in such situations and may be stimulated to replace damaged or lost proteins.
The effect of oxygen deprivation on cardiac protein synthesis is influenced by several factors: first is the degree of O2 deficiency; second is the supply vs. demand [e.g., increased workloads, normal loads, and even cardiac arrest (as in open heart surgery) have entirely different oxygen requirements]; third is the duration of oxygen deprivation. An analysis of the present data appears to emphasize the requirement for maintenance of the protein synthetic mechanism in order to continue cardiac cellular viability. This has been recognized in the working heart in which oxygen deprivation rapidly depletes the heart of its energy stores, and, if continued, a critical level is reached at which even the minimal energy requirement for protein synthesis cannot be met, resynthesis of new proteins is stopped, and loss of viability becomes a certainty. The application of certain forms of cardiac arrest (e.g., [K + ] = 16 mEq/ liter) prevents rapid depletion of high energy phosphates since there is no contraction and cellular protein synthesis and viability have been maintained for periods of several hours. These physiological phenomena have found extensive clinical applications in open heart surgery.
Ethanol and Cardiac Protein Synthesis
Although the hepatic effects of ethanol have long been under study, it is only in the last decade that alcoholic cardiomyopathy has received increasing attention. The condition appears to be independent of associated hepatic disease, vitamin deficiency, or malnutrition (Mitchell and Cohen, 1970) . Cardiac physiological and metabolic change caused by exposure to ethanol have varied with the model used (e.g., in vitro or in vivo), chronicity of exposure, and the presence of coexisting cardiac organic or functional impairment. Thus, depression of contractile function has been reported with prolonged ethanol exposure in vivo (Regan et al., 1966; Segal et al., 1979) , whereas little alteration was seen in vivo unless angiotensin levels were increased (Bing et al., 1974) . Although earlier studies of ethanol-perfused hearts indicated little change in contractile function (Gailis and Verdy, 1971; Schreiber et al., 1972b) , recent examination of this problem in isolated ventricular muscle or open-chest preparations suggests some decrease in function on acute exposure to ethanol (Hirota et al., 1976; Friedman et al., 1979) . Some explanation for the inconsistency in functional data obtained in studies in vivo may be due to the release of varied amounts of acetaldehyde, the primary metabolite of ethanol, which is chronotropic and inotropic. This release may in part antagonize the inhibition of contraction by ethanol.
Cardiac structural and biochemical changes may also vary with the duration of exposure to ethanol and the species' studied; e.g., fibrosis appears in the myocardium of the monkey after 3 months, but ultrastructural changes appear in the rat heart by 6-7 weeks (Regan and Ettinger, 1979) . Mitochondrial appearance and function have been altered with ethanol with changes in enzymatic function preceding altered contractility (Rubin, 1979) , and changes in calcium binding in mitochondria and sarcoplasmic reticulum have been noted with probable inhibition of Na + -K + -activated ATPase (Bing et al., 1974; Rubin, 1979) . Alterations in lipid metabolism with increases in lipid content (Lieber et al., 1966; Regan and Ettinger, 1979 ) and increased incorporation of [ H C]palmitate into triglycerides (Lochner et al., 1969 ) also have been seen.
Ethanol at levels sufficient to inhibit hepatic protein synthesis (Oratz et al., 1977) does not alter synthesis of cardiac proteins or amino acid transport in vitro (Schreiber et al., 1972b) , whereas acetaldehyde inhibits synthesis both in the perfused intact heart and in subcellular systems (Schreiber et al., 1972b (Schreiber et al., , 1974 . The levels causing inhibition of synthesis especially at the microsomal level are found in humans with only moderate intoxication (Kornstein et al., 1975) , and the use of a /?-adrenergic-blocking agent, which effectively prevents the acetaldehyde chronotropic and inotropic effects in the intact heart, does not change inhibition of protein synthesis. Although the inhibition of microsomal protein synthesis recently has been confirmed in tissues obtained from chronically exposed animals (Rawat, 1979) , the mechanism of action is still not clear but apparently requires sarcoplasmic reticulum (Oratz et al., 1977) .
Metabolic and possible structural alterations have been cited for different models of cardiac ethanol toxicity, but the etiology of the cardiomyopathy is still unclear. The findings that protein synthesis may be inhibited by acetaldehyde at levels found in humans invite speculation of the contribution of the derangement of protein metabolism to this condition. Since cardiac protein turnover is rapid (approximately 7-11 days), it is conceivable that repeated release of acetaldehyde into the bloodstream secondary to frequent ethanol ingestion will lead to a net imbalance between syn-608 CIRCULATION RESEARCH VOL. 48, No. 5, MAY 1981 thesis and degradation of total or specific proteins and ultimate cardiac dysfunction.
Summary
It has been the purpose of this review to relate alterations in protein metabolism to cardiac functional or structural changes following some of the major cardiac stresses. It often is difficult to make this connection because it has been generally accepted that since the myofibrillar structure appears the same after neonatal life, the contractile proteins themselves and their proportions in the fibril also remain unchanged. However, not only are there very few recent data supplying specific contractile protein molar proportions in the stresses and resulting pathological situations, but recent information suggests more subtle changes in some stresses (e.g., myosin isozymes, either new or changing in proportion, as well as changes in myosin antigenicity) which would never be apparent on routine chemical or structural examination. These subtle changes may be responsible for the altered myosin ATPase and cardiac dysfunction observed in pathological states.
Although there is a well-known difference between the hypertrophies resulting from preload and afterload, there are few data to explain the difference. Some studies have shown a significant increase in the early response of the protein synthetic mechanism to afterload but not to preload stress, which raises the possibility that there may be an early quantitative difference between the stresses. On the other hand, structural analysis indicates that the sarcomere length is the same in both hypertrophies, yet preloaded myofibrils lengthen and afterloaded myofibrils thicken. Little information is available concerning the assembly of the myofibril in the stresses, but some data have been reported in normal skeletal muscle. In embryonic cells, evidence has been presented that actin, myosin, tropomyosin, and actinin accumulate simultaneously, suggesting that assembly of the myofibril in the developing cell occurs with a full complement of contractile proteins (Allen et al., 1979) . In postnatal and adult tissue, labeled HCs in myosin appear to have a higher specific activity on the surface of the myofibril than in the core, indicating laying down of new fibrillar protein on the surface (Morkin, 1970; Etlinger et al., 1975) . There is, however, rapid mixing with randomization (Zak et al., 1976) . How this is accomplished is still unknown. Two major approaches now are needed; one a systematic investigation of specific protein synthesis in both preload and afterload, and, second, a study, long neglected, of the molecular assembly of the myofibril.
Studies of protein metabolism in cardiac oxygen deprivation have shown that the inhibition of protein synthesis depends on (1) a balance between energy supply and demand, (2) duration of the oxygen deprivation or deficient energy supply, and (3) the status of the protein synthetic mechanism. The evidence obtained from studies of temporary anoxia and/or ischemia, and cardiac arrest indicate that the maintenance of a protein synthetic system may ensure continued cell viability.
Ethanolic cardiomyopathy has been well described and metabolic alterations and possible contractile dysfunction in chronic ethanol exposure frequently but not consistently reported, but there are no consistent data relating the above dysfunctions to the cardiomyopathy, nor is a sequence of events known which leads from ethanol ingestion to the disease. The recent findings of inhibition of protein synthesis by an ethanol metabolite raises the question whether the ultimate cardiac decompensation is not due to impaired contractile systems, a resultant of subnormal synthesis.
The examples of the protein metabolic responses to the different stresses summarized above would suggest that studies of synthesis of specific proteins would be more advantageous in defining mechanisms of development of pathology than the study of the ultimate pathological state. The data also suggest that maintenance of cell viability is dependent on the integrity of the protein synthetic mechanism.
